Matthew David

Matthew David

Chief Financial OfficeratCorMedix· In proxies 2022–2024

Pay in FY2024+6% from the year before · CorMedix stock +115.4% the same year

Matthew David was paid $1.1M in FY2024 (Dec), up 6%. CorMedix stock rose 115.4% that year.

Pay$100 in the stock at the end of FY21 → $178
Pay is from the Summary Compensation Table of each CorMedix proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. CorMedixPublic company · 4 yr
    • Chief Financial Officer2022 – Present · 4 yrStock in role +70%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?